Table 1. Demographic Data and Laboratory Characteristics of the Two Groups.

From: Coronary Lesions and Systemic Inflammatory Response Syndrome in Kawasaki Disease

non-SIRS SIRS p-value
N = 102 N = 175
Gender (male) 62 (60.8) 102 (58.3) 0.71
Age (months) 25.5 (15.7) 34.6 (23.9) < 0.001
Days of illness 4.12 (1.86) 4.20 (2.18) 0.77
Vital signs
Body temperature (℃) 38.3 (0.51; 102) 39.1 (0.70; 175) < 0.001
Heart rate (bpm) 152 (22.1; 101) 159 (25.0; 175) 0.02
Respiratory rate (/min) 33.4 (7.83; 87) 34.6 (9.62; 157) 0.29
Laboratory findings
WBC (103/µL) 12.2 (3.52; 101) 14.9 (4.82; 174) < 0.001
Neutrophils (%) 62.6 (15.5; 101) 71.1 (15.4; 174) < 0.001
Platelets (104/µL) 34.9 (12.7; 100) 34.3 (12.4; 172) 0.77
Sodium (mmol/L) 135 (2.89; 101) 133 (2.94; 172) 0.001
AST (U/L) 64.6 (83.2; 101) 113 (242; 172) 0.02
ALT (U/L) 70.7 (113; 101) 108 (165; 174) 0.03
CRP (mg/dL) 6.29 (4.45; 101) 7.50 (4.03; 174) 0.02
Albumin (g/dL) 3.66 (0.47; 99) 3.57 (0.40; 170) 0.09
Total cholesterol (mg/dL) 148 (24.0; 94) 144 (27.2; 157) 0.29
Kobayashi score 2.93 (2.53; 102) 3.81 (2.63; 175) 0.01
Kobayashi score ≥ 5 21 (20.6) 63 (36.0) 0.007
Table 2. Clinical Outcomes of the Two Groups.

From: Coronary Lesions and Systemic Inflammatory Response Syndrome in Kawasaki Disease

non-SIRS SIRS
N = 102 N = 175 p-value
Z-score of the coronary artery at 1 week of the clinical course
RCA 1.36 (1.79) 1.54 (1.74) 0.41
LMCA 1.96 (0.83) 2.0 (1.07) 0.74
LAD 1.25 (1.13) 1.42 (1.45) 0.31
Z-score of the coronary artery at 1 month after treatment
RCA 0.92 (1.84) 1.09 (1.73) 0.45
LMCA 1.63 (0.92) 1.54 (1.0) 0.45
LAD 0.92 (1.16) 0.98 (1.48) 0.71
CAL at week 1 8 (7.8) 31 (17.7) 0.03
CAL at month 1 4 (3.9) 19 (10.9) 0.03
IVIG resistancea 10 (10.5) 12 (7.0) 0.36
Table 3. Multivariate Analyses for CAL at Week 1 and at 1 Month after Treatment.

From: Coronary Lesions and Systemic Inflammatory Response Syndrome in Kawasaki Disease

CAL at week 1 CAL at month 1
OR 95% CI p-value OR 95% CI p-value
SIRS 2.7 1.03–7.23 0.04 3.0 0.81–11.1 0.10
Kobayashi score variables
Illness days 1.2 0.96–1.39 0.13 1.2 0.98–1.47 0.08
CRP 1.1 1.03–1.24 0.01 1.1 0.97–1.22 0.14
Neutrophils 1.0 0.98–1.07 0.29 1.0 0.97–1.09 0.31
Platelets 1.0 0.97–1.04 0.83 1.0 0.95–1.05 0.98
AST 1.0 0.99–1.00 0.99 1.0 0.99–1.00 0.65
Sodium 1.0 0.86–1.16 0.99 0.94 0.79–1.13 0.52
Months of age 1.0 0.98–1.002 0.96 1.0 0.97–1.02 0.81
Table 4. Clinical Characteristics of the Two Patient Groups with a Kobayashi Score < 5.

From: Coronary Lesions and Systemic Inflammatory Response Syndrome in Kawasaki Disease

non-SIRS SIRS p-value
N = 90 N = 114
Gender (male) 57 (63.3) 67 (58.8) 0.51
Age (months) 24.6 (18.0) 31.8 (23.4) 0.01
Z-score of the coronary artery at 1 week of the clinical course
RCA 1.18 (1.19) 1.32 (1.29) 0.44
LMCA 1.98 (0.64) 1.89 (1.01) 0.51
LAD 1.17 (0.94) 1.24 (1.0) 0.57
Z-score of the coronary artery at 1 month after treatment
RCA 0.80 (1.20) 0.86 (1.21) 0.71
LMCA 1.64 (0.71) 1.44 (0.93) 0.10
LAD 0.91 (0.89) 0.82 (1.03) 0.52
CAL at week 1 5 (5.6) 18 (15.8) 0.03
CAL at month 1 2 (2.2) 9 (7.9) 0.12
IVIG resistance 14 (15.6) 16 (14.0) 0.84
PAGE TOP